Individualized Timing of Analgesia and Effectiveness of Labor Analgesia
Labor Pain, Analgesia, Obstetrical, Early Medical Intervention
About this trial
This is an interventional prevention trial for Labor Pain focused on measuring severity of labor pain, individualized administration, neuraxial labor analgesia
Eligibility Criteria
Inclusion Criteria:
- Nulliparas (aged 18-36 years) with single cephalic term pregnancy;
- Plan to deliver vaginally, and are considered suitable for a trial of vaginal delivery by obstetricians;
- Admitted to the delivery room;
- Agree to receive epidural analgesia during labor.
Exclusion Criteria:
- History of psychiatric disease (indicate those that are diagnosed before or during pregnancy by psychiatrists);
- Presence of contraindications to epidural analgesia, which includes: (1) History of infectious disease of the central nervous system (poliomyelitis, cerebrospinal meningitis, encephalitis, etc.); (2) History of spinal or intra-spinal disease (trauma or surgery of spinal column, intra-spinal canal mass, etc.); (3) Systemic infection (sepsis); (4) Skin or soft tissue infection at the site of epidural puncture; (5) Coagulopathy.
- Other reasons that are considered unsuitable for study participation.
Sites / Locations
- Peking University First Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Individualized epidural analgesia
Routine epidural analgesia
Epidural catheterization will be performed after the beginning of the first stage of labor. Epidural analgesia will begin when asked by parturients and the numeric rating scale of pain is 5 or higher. A loading dose (10 ml mixture of 0.1% ropivacaine and 0.5 ug/ml sufentanil) will be administered through the epidural catheter. After a 20-minute observation, a patient-controlled analgesia pump (containing a mixture of 0.08% ropivacaine and 0.4 ug/ml sufentanil) will be connected to the epidural catheter and programmed to deliver a 6-ml bolus with a 20-minute lockout interval and a 4 ml/h background infusion. Analgesia will be terminated at the end of the third stage of labor.
Epidural catheterization will be performed after the beginning of the first stage of labor and the cervix is dilated to 1 cm or more. Epidural analgesia will then begin. A loading dose (10 ml mixture of 0.1% ropivacaine and 0.5 ug/ml sufentanil) will be administered through the epidural catheter. After a 20-minute period observation, a patient-controlled analgesia pump (containing a mixture of 0.08% ropivacaine and 0.4 ug/ml sufentanil) will be connected to the epidural catheter and programmed to deliver a 6-ml bolus with a 20-minute lockout interval and a 4 ml/h background infusion. Analgesia will be terminated at the end of the third stage of labor.